Jérôme Biton

3.1k citations

35 papers · 2.2k indexed · 1 hit paper · h-index 22

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 24
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 8
- IL-33, ST2, and ILC Pathways 4
Oncology 16
- Cancer Immunotherapy and Biomarkers 9
- Cytokine Signaling Pathways and Interactions 4

Co-authors: Marco Alifano (13 shared papers)Diane Damotte (13 shared papers)Marie‐Christophe Boissier (21 shared papers)Hanane Ouakrim (7 shared papers)Natacha Bessis (19 shared papers)Audrey Lupo (5 shared papers)Isabelle Cremer (10 shared papers)Marie‐Caroline Dieu‐Nosjean (8 shared papers)
Journals: Annals of the Rheumatic Diseases (3 papers)The Journal of Immunology (3 papers)Arthritis & Rheumatology (3 papers)Frontiers in Immunology (2 papers)OncoImmunology (2 papers)
Partner nations: France Czechia United Kingdom

In The Last Decade

Jérôme Biton

33 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment 2018 · 631 citations

Peers

Countries citing papers authored by Jérôme Biton

Since Specialization

Citations

This map shows the geographic impact of Jérôme Biton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Biton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Biton more than expected).

Fields of papers citing papers by Jérôme Biton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Biton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Biton. The network helps show where Jérôme Biton may publish in the future.

Co-authors

The 25 scholars most cited alongside Jérôme Biton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jérôme Biton Line = papers co-authored together Jérôme Biton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment Proceedings of the National Academy of Sciences ·Elisa Peranzoni, Jean Lemoine, Lene Vimeux, Vincent Feuillet, Sarah Barrin, Chahrazade Kantari‐Mimoun, Nadège Bercovici, Marion V. Guérin, Jérôme Biton, Hanane Ouakrim, Fabienne Régnier, Audrey Lupo, Marco Alifano, Diane Damotte, Emmanuel Donnadieu Hit paper breakdown →	2018	631
2	TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma Clinical Cancer Research ·Jérôme Biton, Audrey Mansuet‐Lupo, Nicolas Pécuchet, Marco Alifano, Hanane Ouakrim, Jennifer Arrondeau, Pascaline Boudou‐Rouquette, François Goldwasser, Karen Leroy, Jérémy Goc, Marie Wislez, Claire Germain, Pierre Laurent‐Puig, Marie‐Caroline Dieu‐Nosjean, Isabelle Cremer, Ronald Herbst, Hélène Blons, Diane Damotte	2018	251
3	Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis Cancer Research ·Jitka Fučíková, Étienne Becht, Kristina Iribarren, Jérémy Goc, Romain Remark, Diane Damotte, Marco Alifano, Priyanka Devi-Marulkar, Jérôme Biton, Claire Germain, Audrey Lupo, Wolf H. Fridman, Marie‐Caroline Dieu‐Nosjean, Guido Kroemer, Catherine Sautès‐Fridman, Isabelle Cremer	2016	159
4	Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer PLoS ONE ·Marco Alifano, Audrey Mansuet‐Lupo, Filippo Lococo, Nicolás Roche, Antonio Bobbio, Emelyne Canny, Olivier Schussler, Hervé Dermine, Jean-François Régnard, Barbara Burroni, Jérémy Goc, Jérôme Biton, Hanane Ouakrim, Isabelle Cremer, Marie‐Caroline Dieu‐Nosjean, Diane Damotte	2014	135
5	Regulatory T cells (Treg) in rheumatoid arthritis Joint Bone Spine ·Marie‐Christophe Boissier, Éric Assier, Jérôme Biton, Anne Denys, Géraldine Falgarone, Natacha Bessis	2008	100
6	Interleukin‐6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis Arthritis & Rheumatology ·Allan Thiolat, Luca Semerano, Yves‐Marie Pers, Jérôme Biton, Delphine Lemeiter, Pierre Portalès, J. Quentin, Christian Jørgensen, Patrice Decker, Marie‐Christophe Boissier, Pascale Louis‐Plence, Natacha Bessis	2013	98
7	The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status CHEST Journal ·Audrey Mansuet‐Lupo, Antonio Bobbio, Hélène Blons, Étienne Becht, Hanane Ouakrim, Audrey Didelot, Marie-Christine Charpentier, Serge Bain, B Marmey, Patricia Bonjour, Jérôme Biton, Isabelle Cremer, Marie‐Caroline Dieu‐Nosjean, Catherine Sautès‐Fridman, Jean‐François Régnard, Pierre Laurent‐Puig, Marco Alifano, Diane Damotte	2014	76
8	Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients OncoImmunology ·Romain Remark, Audrey Lupo, Marco Alifano, Jérôme Biton, Hanane Ouakrim, Alessandro Di Stefani, Isabelle Cremer, Jérémy Goc, Jean‐François Régnard, Marie‐Caroline Dieu‐Nosjean, Diane Damotte	2016	67
9	Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis The Journal of Immunology ·Jérôme Biton, Luca Semerano, Laure Delavallée, Delphine Lemeiter, Marion Laborie, Géraldine Grouard-Vogel, Marie‐Christophe Boissier, Natacha Bessis	2011	61
10	Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors Journal of Thoracic Oncology ·Audrey Mansuet‐Lupo, Marc Barritault, Marco Alifano, Aurélie Janet-Vendroux, Makmoud Zarmaev, Jérôme Biton, Yoan Velut, Christine Le Hay, Isabelle Cremer, Jean‐François Régnard, Ludovic Fournel, Bastien Rance, Marie Wislez, Pierre Laurent‐Puig, Ronald Herbst, Diane Damotte, Hélène Blons	2019	59
11	Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients Frontiers in Immunology ·Claire Germain, Priyanka Devi-Marulkar, Samantha Knockaert, Jérôme Biton, Hélène Kaplon, Laïla Letaïef, Jérémy Goc, Agathe Seguin‐Givelet, Dominique Gossot, Nicolas Girard, Pierre Validire, Marine Lefèvre, Diane Damotte, Marco Alifano, François M. Lemoine, Keith E. Steele, Jean‐Luc Teillaud, Scott A. Hammond, Marie‐Caroline Dieu‐Nosjean	2021	58
12	Air pollution as a determinant of rheumatoid arthritis Joint Bone Spine ·Johanna Sigaux, Jérôme Biton, Emma André, Luca Semerano, Marie‐Christophe Boissier	2018	56
13	Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations American Journal of Respiratory and Critical Care Medicine ·Audrey Mansuet‐Lupo, Marco Alifano, Nicolas Pécuchet, Jérôme Biton, Étienne Becht, Jérémy Goc, Claire Germain, Hanane Ouakrim, Jean‐François Régnard, Isabelle Cremer, Pierre Laurent‐Puig, Marie‐Caroline Dieu‐Nosjean, Hélène Blons, Diane Damotte	2016	49
14	Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome OncoImmunology ·Véronique M. Braud, Jérôme Biton, Étienne Becht, Samantha Knockaert, Audrey Mansuet‐Lupo, Estelle Cosson, Diane Damotte, Marco Alifano, Pierre Validire, Fabienne Anjuère, Isabelle Cremer, Nicolas Girard, Dominique Gossot, Agathe Seguin‐Givelet, Marie‐Caroline Dieu‐Nosjean, Claire Germain	2018	49
15	In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis The Journal of Immunology ·Jérôme Biton, Seyyed Shamsadin Athari, Allan Thiolat, François Santinon, Delphine Lemeiter, Roxane Hervé, Laure Delavallée, Anaïs Levescot, Stéphane Roga, Patrice Decker, Jean‐Philippe Girard, André Herbelin, Marie‐Christophe Boissier, Natacha Bessis	2016	47
16	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice Cytokine ·Allan Thiolat, Anne Denys, Marie Petit, Jérôme Biton, Delphine Lemeiter, Roxane Hervé, Didier Lutomski, Marie‐Christophe Boissier, Natacha Bessis	2014	43
17	TNFα: Activator or inhibitor of regulatory T cells? Joint Bone Spine ·Jérôme Biton, Marie‐Christophe Boissier, Natacha Bessis	2011	37
18	Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis Arthritis & Rheumatology ·François Santinon, Maxime Batignes, Majda Lyna Mebrek, Jérôme Biton, Gaëlle Clavel, Roxane Hervé, Delphine Lemeiter, Magali Breckler, Florence Busato, Jörg Tost, Marianne Ziol, Marie‐Christophe Boissier, Patrice Decker, Luca Semerano, Natacha Bessis	2019	32
19	Origins of rheumatoid arthritis Joint Bone Spine ·Marie‐Christophe Boissier, Jérôme Biton, Luca Semerano, Patrice Decker, Natacha Bessis	2019	31
20	SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils Lung Cancer ·Yoan Velut, Elise Decroix, Hélène Blons, Marco Alifano, Karen Leroy, Florent Petitprez, Aurélie Boni, Simon Garinet, Jérôme Biton, Isabelle Cremer, Marie Wislez, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, François Goldwasser, Ludovic Fournel, Diane Damotte, Audrey Mansuet‐Lupo	2022	29

About Jérôme Biton

Jérôme Biton is a scholar working on Immunology, Oncology, Rheumatology, Health, Toxicology and Mutagenesis and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers), Systemic Lupus Erythematosus Research (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.1k citations), Cancer Research (245 citations), Pulmonary and Respiratory Medicine (516 citations) and Rheumatology (200 citations). Jérôme Biton has collaborated with scholars based in France, Czechia and United Kingdom. Frequent co-authors include Marco Alifano, Diane Damotte, Marie‐Christophe Boissier, Hanane Ouakrim, Natacha Bessis, Audrey Lupo, Isabelle Cremer, Marie‐Caroline Dieu‐Nosjean, Jérémy Goc and Chahrazade Kantari‐Mimoun. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, Arthritis & Rheumatology, Frontiers in Immunology and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact